Timing of cardiac magnetic resonance and diagnostic yield in patients with myocardial infarction with nonobstructive coronary arteries
Revista Española de Cardiología (English Edition) · 2024-07 · 77 (7) · 515-523
DOI: 10.1016/j.rec.2023.11.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Española de Cardiología (English Edition), 2024-07. Verfasst von Gladys Juncà und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto del Corazón, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Cine, Myocardial Infarction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION AND OBJECTIVES: The present study sought to establish the diagnostic yield of cardiovascular magnetic resonance (CMR) in a large cohort of patients admitted with myocardial infarction (MI) with nonobstructive coronary artery disease (MINOCA) based on the timing of referral to CMR. METHODS: Consecutive patients referred to CMR from January 2009 to February 2022 with a working diagnosis of MINOCA were retrospectively evaluated. Cine, T2-weighted, early, and late gadolinium-enhanced images were acquired and analyzed. The frequency of the underlying diagnosis and the association between timing of CMR and relative frequency of each diagnosis were assessed. RESULTS: We included 207 patients (median age 50 years, 60% men). Final diagnosis after CMR was achieved in 91% of the patients (myocarditis in 45%, MI in 20%, tako-tsubo cardiomyopathy in 19%, and other cardiomyopathies in 7%). The performance of CMR within 7 days of admission with MINOCA (median, 5 days; 117 patients) allowed a higher diagnostic yield compared with CMR performed later (median, 10 days; 88 patients) (96% vs 86%, P=.02). Although myocarditis was the most frequent diagnosis in both groups according to time to CMR, its frequency was higher among patients with a CMR performed within the first 7 days (53% vs 35%, P=.02). The frequency of other underlying diagnoses was not influenced by CMR timing. CONCLUSIONS: CMR led to an underlying diagnosis of MINOCA in 91% of patients and its diagnostic yield increased to 96% when CMR was performed within 7 days of admission. The most frequent diagnosis was myocarditis..
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto del Corazón, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
- Instituto del Corazón, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain; Departamento de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedad…
- Instituto del Corazón, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain. Electronic address: vdelgadog.germanstrias@gencat.cat.
Zitieren
APA
Juncà, G., Teis, A., Kasa, G., Ferrer-Sistach, E., Vallejo, N., López-Ayerbe, J., Cediel, G., Bayés-Genís, A., & Delgado, V. (2024). Timing of cardiac magnetic resonance and diagnostic yield in patients with myocardial infarction with nonobstructive coronary arteries. Revista Española de Cardiología (English Edition), 77(7), 515-523. https://doi.org/10.1016/j.rec.2023.11.013
Vancouver
Juncà G, Teis A, Kasa G, Ferrer-Sistach E, Vallejo N, López-Ayerbe J, et al. Timing of cardiac magnetic resonance and diagnostic yield in patients with myocardial infarction with nonobstructive coronary arteries. Revista Española de Cardiología (English Edition). 2024;77(7):515-523. doi:10.1016/j.rec.2023.11.013
BibTeX
@article{Junc2024,
author = {Juncà, Gladys and Teis, Albert and Kasa, Gizem and Ferrer-Sistach, Elena and Vallejo, Nuria and López-Ayerbe, Jorge and Cediel, Germán and Bayés-Genís, Antoni and Delgado, Victoria},
title = {Timing of cardiac magnetic resonance and diagnostic yield in patients with myocardial infarction with nonobstructive coronary arteries},
journal = {Revista Española de Cardiología (English Edition)},
year = {2024},
volume = {77},
number = {7},
pages = {515--523},
doi = {10.1016/j.rec.2023.11.013}
}
EUVIMED